{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:34:13Z","timestamp":1783766053932,"version":"3.55.0"},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1002\/ajh.24942","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T06:52:34Z","timestamp":1507877554000},"page":"5-7","source":"Crossref","is-referenced-by-count":2,"title":["Revisiting the need for bone marrow examination in chronic myeloid leukemia"],"prefix":"10.1002","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-3821","authenticated-orcid":false,"given":"Ayalew","family":"Tefferi","sequence":"first","affiliation":[{"name":"Divisions of Hematology Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Divisions of Hematopathology Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[{"name":"Divisions of Laboratory Genetics and Genomics, Departments of Internal and Laboratory Medicine Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"e_1_2_3_2_1","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell PC","year":"1960","journal-title":"J Natl Cancer Inst."},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/243290a0"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(84)90077-1"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/315758a0"},{"issue":"8377","key":"e_1_2_3_6_1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(84)90997-8","article-title":"Altered transcription of an oncogene in chronic myeloid leukaemia","volume":"1","author":"Canaani E","year":"1984","journal-title":"Lancet."},{"issue":"4657","key":"e_1_2_3_7_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.6587568","article-title":"Altered transcription of the c\u2010abl oncogene in K\u2010562 and other chronic myelogenous leukemia cells","volume":"225","author":"Collins SJ","year":"1984","journal-title":"Science."},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/315550a0"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198512053132301"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3460176"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.17.6649"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2406902"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb08212.x"},{"key":"e_1_2_3_14_1","article-title":"ISCN 2009: An international system for human cytogenetic nomenclature (2009): Recommendations of the international standing committee on human cytogenetic nomenclature basel","author":"Shaffer LG","year":"2009","journal-title":"Karger."},{"issue":"1","key":"e_1_2_3_15_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(03)00202-4","article-title":"A novel tricolor, dual\u2010fusion fluorescence in situ hybridization method to detect BCR\/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia","volume":"148","author":"Smoley SA","year":"2004","journal-title":"Cancer Genet Cytogenet."},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2013.04.007"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0596-561"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609324"},{"key":"e_1_2_3_21_1","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2017.253","article-title":"Assessment of imatinib as first\u2010line treatment of chronic myeloid leukemia: 10\u2010year survival results of the randomized CML study IV and impact of non\u2010CML determinants","author":"Hehlmann R","year":"2017","journal-title":"Leukemia."},{"key":"e_1_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2016.1201214"},{"key":"e_1_2_3_23_1","article-title":"Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia","author":"Kwak JY","year":"2017","journal-title":"Clin Cancer Res."},{"issue":"8","key":"e_1_2_3_24_1","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.3324\/haematol.2015.139089","article-title":"Frontline therapy with high\u2010dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic\u2010phase chronic myeloid leukemia \u2010 a propensity score analysis","volume":"101","author":"Sasaki K","year":"2016","journal-title":"Haematologica."},{"key":"e_1_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.03.003"},{"key":"e_1_2_3_26_1","article-title":"Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey","author":"Begna K","year":"2017","journal-title":"Am J Hematol."},{"key":"e_1_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24838"},{"key":"e_1_2_3_28_1","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24887","article-title":"First\u2010line treatment selection and early monitoring patterns in chronic phase\u2010chronic myeloid leukemia in routine clinical practice: SIMPLICITY","author":"Goldberg SL","year":"2017","journal-title":"Am J Hematol."},{"key":"e_1_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-742205"},{"key":"e_1_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.63"},{"key":"e_1_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.2914"},{"key":"e_1_2_3_32_1","unstructured":"VardimanJW MeloJV BaccaraniM et al. Chronic myeloid leukemia BCR\u2010ABL1\u2010positive. In: Swerdlow SHea editor. WHO classification of tumours of haematopoietic and lymhoid tissues. Lyon France;2017."},{"key":"e_1_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569"},{"key":"e_1_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404917"},{"key":"e_1_2_3_35_1","article-title":"Prognostic significance of clonal evolution at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors","author":"Alhuraiji A","year":"2017","journal-title":"American Journal of Hematology."},{"key":"e_1_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600783551"},{"key":"e_1_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-229864"},{"issue":"3","key":"e_1_2_3_38_1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/ajcp\/aqw008","article-title":"Is It Time for a New Gold Standard? FISH vs Cytogenetics in AML Diagnosis","volume":"145","author":"Hammer RD","year":"2016","journal-title":"Am J Clin Pathol."}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.24942","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.24942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:15:09Z","timestamp":1695539709000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.24942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1002\/ajh.24942"],"URL":"https:\/\/doi.org\/10.1002\/ajh.24942","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,3]]}}}